Portage Biotech Inc. Files Routine 6-K Report

Ticker: ATON · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1095435

Portage Biotech INC. 6-K Filing Summary
FieldDetail
CompanyPortage Biotech INC. (ATON)
Form Type6-K
Filed DateAug 15, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-issuer

TL;DR

Portage Biotech filed a 6-K, just a routine check-in, no big news.

AI Summary

Portage Biotech Inc. filed a Form 6-K on August 15, 2024, reporting its status as a foreign private issuer. The company, incorporated in the British Virgin Islands, maintains its principal executive offices in Tortola. This filing is routine and does not disclose specific financial transactions or material events.

Why It Matters

This filing indicates ongoing compliance with SEC reporting requirements for foreign private issuers, ensuring transparency for investors.

Risk Assessment

Risk Level: low — This is a standard, routine filing with no new material information or financial disclosures that would inherently increase risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have distributed or are required to distribute to their security holders.

When was Portage Biotech Inc. incorporated?

The filing indicates Portage Biotech Inc. is incorporated in the British Virgin Islands.

What is the principal executive office address for Portage Biotech Inc.?

The principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.

Does Portage Biotech Inc. file annual reports under Form 20-F?

Yes, the filing indicates Portage Biotech Inc. files or will file annual reports under cover of Form 20-F.

Who is listed as the company contact person and their contact details?

Ian Walters is listed as the company contact person, with a phone number of 203.221.7378 and an address at c/o Portage Development Services Inc., 61 Wilton Road, Westport, Connecticut 06880.

Filing Stats: 269 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-08-15 08:00:08

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Portage Biotech Inc. (Registrant) Date: August 15, 2024 /s/ Allan Shaw Allan Shaw Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing